
5-(2-Furyl)-2-hydroxybenzoic acid
CAS No. 893739-96-3
5-(2-Furyl)-2-hydroxybenzoic acid( —— )
Catalog No. M35971 CAS No. 893739-96-3
5-(2-Furyl)-2-hydroxybenzoic acid is an inhibitor of glycolate oxidase (GO) and can be used to study metabolism-related disorders such as primary hyperoxaluria type 1 (PH1).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 160 | Get Quote |
![]() ![]() |
5MG | 242 | Get Quote |
![]() ![]() |
10MG | 357 | Get Quote |
![]() ![]() |
25MG | 576 | Get Quote |
![]() ![]() |
50MG | 818 | Get Quote |
![]() ![]() |
100MG | 1062 | Get Quote |
![]() ![]() |
500MG | 2403 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name5-(2-Furyl)-2-hydroxybenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description5-(2-Furyl)-2-hydroxybenzoic acid is an inhibitor of glycolate oxidase (GO) and can be used to study metabolism-related disorders such as primary hyperoxaluria type 1 (PH1).
-
DescriptionLDH-IN-2, a salicylic acid derivative, is an inhibitor of glycolate oxidase (GO). LDH-IN-2 decreases oxalate output in hyperoxaluric hepatocytes. LDH-IN-2 can be used for research of primary hyperoxaluria type 1 (PH1).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number893739-96-3
-
Formula Weight204.18
-
Molecular FormulaC11H8O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C=1C=C(C=CC1O)C=2OC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moya-Garzón MD, et al. Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1. J Med Chem. 2018 Aug 23;61(16):7144-7167. ?
molnova catalog



related products
-
Cyanidin-3-O-lathyro...
Cyanidin-3-O-lathyroside chloride is a natural product for research related to life sciences.
-
PF-06446846
PF?06446846 is a potent and selective PCSK9 inhibitor?PF-06446846 reduces plasma PCSK9 and total cholesterol levels in rats following oral dosing.?
-
SR10067
SR10067 is a potent, selective and brain penetrant agonist of Rev-Erbβ(IC50 = 160 nM) and Rev-Erbα(IC50 = 170 nM) with anxiolytic activity.